SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-021381
Filing Date
2021-04-28
Accepted
2021-04-28 16:22:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A crsp-defa14a_20210610.htm DEFA14A 48006
2 GRAPHIC g5sfjnvimfyn000001.jpg GRAPHIC 441306
3 GRAPHIC g5sfjnvimfyn000002.jpg GRAPHIC 429341
  Complete submission text file 0001564590-21-021381.txt   1247954
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37923 | Film No.: 21864532
SIC: 2836 Biological Products, (No Diagnostic Substances)